OPPM
NKTR icon

Opus Point Partners Management’s Nektar Therapeutics NKTR Stock Holding History

Opus Point Partners Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$235K Buy
862
+28
+3% +$10.3K 0.42% 50
2019
Q2 		$445K Buy
834
+147
+21% +$73.7K 0.66% 41
2019
Q1 		$346K Sell
687
-195
-22% -$116K 0.47% 51
2018
Q4 		$435K Buy
882
+95
+12% +$57.3K 0.96% 19
2018
Q3 		$720K Buy
787
+218
+38% +$186K 1.72% 23
2018
Q2 		$417K Sell
569
-993
-64% -$1.15M 0.9% 29
2018
Q1 		$2.49M Sell
1,562
-4,576
-75% -$5.9M 4.88% 3
2017
Q4 		$5.5M Sell
6,138
-817
-12% -$483K 4.76% 5
2017
Q3 		$2.5M Buy
6,955
+475
+7% +$149K 2.25% 12
2017
Q2 		$1.9M Sell
6,480
-5,939
-48% -$1.72M 1.74% 22
2017
Q1 		$4.37M Buy
12,419
+130
+1% +$29.2K 3.25% 8
2016
Q4 		$2.26M Buy
12,289
+515
+4% +$105K 1.8% 27
2016
Q3 		$3.03M Sell
11,774
-128
-1% -$33K 1.7% 17
2016
Q2 		$2.54M Sell
11,902
-7,309
-38% -$1.63M 2.45% 16
2016
Q1 		$3.96M Sell
19,211
-4,028
-17% -$774K 3.06% 9
2015
Q4 		$5.87M Sell
23,239
-6,378
-22% -$1.31M 3.88% 5
2015
Q3 		$4.87M Buy
29,617
+5,086
+21% +$900K 2.69% 12
2015
Q2 		$4.6M Buy
24,531
+2,154
+10% +$371K 3.65% 7
2015
Q1 		$3.69M Buy
22,377
+6,570
+42% +$1.35M 3.09% 17
2014
Q4 		$3.68M Buy
+15,807
New +$3.38M 3.64% 6

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Opus Point Partners Management's NKTR Position: Q3 2019 in Review

Opus Point Partners Management increased its Nektar Therapeutics (NKTR) stake by 3.4% in Q3 2019, buying an estimated $10.3K and bringing the position to 862 shares worth $235K. The position accounts for 0.42% of the portfolio, ranked #50.

Opus Point Partners Management first reported a position in NKTR in Q4 2014 and has held it in 20 quarters since. The position peaked at $5.87M in Q4 2015. 288 funds tracked by Wall St. Rank hold NKTR as of Q3 2019.

  • Opus Point Partners Management held 862 shares of Nektar Therapeutics worth $235K as of Q3 2019.
  • Opus Point Partners Management bought 28 Nektar Therapeutics shares in Q3 2019, an estimated $10.3K.
  • Nektar Therapeutics made up 0.42% of Opus Point Partners Management's portfolio in Q3 2019, its #50 holding.
  • Opus Point Partners Management first reported a position in Nektar Therapeutics in Q4 2014 and has held it in 20 quarters since.
  • Opus Point Partners Management's Nektar Therapeutics position peaked at $5.87M in Q4 2015.
  • 288 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.